These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17867897)

  • 1. [Metabolic alterations, AIDS and vascular disease].
    Betancor León P
    An Med Interna; 2007 Apr; 24(4):157-9. PubMed ID: 17867897
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic syndrome: news from the 4th International AIDS Society Conference.
    Valenti WM
    AIDS Read; 2007 Sep; 17(9):435-7. PubMed ID: 17902223
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
    Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
    Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term tolerance. Favorable lipid profile--favorable effect on development of lipodystrophy?].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():17. PubMed ID: 15373036
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolic syndrome in HIV.
    Worm SW; Lundgren JD
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):479-86. PubMed ID: 21663841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
    Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
    J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
    De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P;
    J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction. Residual atherothrombotic risk. Does it exist?].
    Tavazzi L; Ambrosio G
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):3S-5S. PubMed ID: 18773745
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
    Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
    HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does HIV cause cardiovascular disease?
    Carr A; Ory D
    PLoS Med; 2006 Nov; 3(11):e496. PubMed ID: 17132070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions.
    Kotler DP
    Liver Int; 2009 Mar; 29 Suppl 2():38-46. PubMed ID: 19187071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment: the head bone is connected to the body bone.
    Fichtenbaum CJ
    AIDS Read; 2008 May; 18(5):265. PubMed ID: 18589481
    [No Abstract]   [Full Text] [Related]  

  • 20. Persons with HIV/AIDS face downside of living longer.
    AIDS Read; 2008 Mar; 18(3):C2. PubMed ID: 18401874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.